Diagnostics channel feed

Di­ag­nos­tics out­fit lays off third of em­ploy­ees, now look­ing at 's­trate­gic al­ter­na­tives'

2 weeks ago
People

FDA warns some Il­lu­mi­na DNA se­quenc­ing de­vices could be vul­ner­a­ble to hack­ers

Last month
FDA+

Quest Di­ag­nos­tics buys Bert Vo­gel­stein’s Haystack On­col­o­gy, just six months af­ter Se­ries A

Last month
Deals

Pat­tern Bio­science rais­es $28.7M Se­ries C for faster, more ef­fi­cient an­tibi­ot­ic re­sis­tance test

Last month
Financing

As show­down with ac­tivist nears, Il­lu­mi­na’s CEO de­fends the com­pa­ny’s $7.1B pur­chase of Grail

Last month
Deals

Ex-US Com­merce Sec­re­tary Wilbur Ross pairs his SPAC with Alzheimer's biotech

4 months ago
Startups
Deals

Qi­a­gen picks up DNA foren­sics com­pa­ny for $150M

4 months ago
Deals

Ther­mo Fish­er wa­gers on ear­ly can­cer di­ag­nos­tics in $2.6B cash deal for mul­ti­ple myelo­ma test mak­er

7 months ago
Deals

Af­ter block­ing Grail ac­qui­si­tion, EU leaves Il­lu­mi­na with few good op­tions

9 months ago
Deals

Chi­na's DNA gi­ant con­fronts skep­ti­cism in US ex­pan­sion bid

9 months ago
China
In Focus

Ko­re­an di­ag­nos­tics biotech goes transpa­cif­ic, agree­ing to shell out $1.5B to take Merid­i­an pri­vate

11 months ago
Deals

As new mon­key­pox cas­es spike glob­al­ly, Lab­corp rolls out first na­tion­al lab test

11 months ago
Pharma

Roche's ROS1+ can­cer drug gets FDA green­light for Foun­da­tion Med­i­cine's com­pan­ion di­ag­nos­tic

12 months ago
Pharma

Pre­ci­sion drug + di­ag­nos­tics biotech scores mod­est Se­ries A, retro­fitting ex­ist­ing drug for new in­di­ca­tion

Last year
Financing

Bay Area ge­nomics start­up emerges from stealth with $600M in the bank and promis­ing a '$100 genome' test

Last year
Startups

Guardant Health fires back at Il­lu­mi­na suit, claim­ing re­tal­i­a­tion over its role in FTC an­titrust in­ves­ti­ga­tion

Last year
Law

Roche un­veils three new mon­key­pox tests as cas­es rise

Last year
Pharma

Can On­co­Host's PROphet pre­dict host re­sponse to can­cer treat­ments? In­vestors are wait­ing to find out

Last year
Financing

Wait, what? Or­a­cle tech founder Lar­ry El­li­son in­vests in­to ex-stealth ge­nomics di­ag­nos­tics biotech

Last year
AI

Bay­er, GSK, No­var­tis and Roche jump­start bio­mark­er can­cer or­ga­ni­za­tion to dri­ve tests for all

Last year
Pharma
Marketing

Pre­ci­sion di­ag­nos­tics biotech wins newest round of in­vestor back­ing in bid to fa­cil­i­tate com­pa­ny ex­pan­sion

Last year
Pharma

An­oth­er biotech is feel­ing the heat as it un­der­goes 're­or­ga­ni­za­tion' with plans to lay off about 100

Last year
People

Sher­lock, Feng Zhang's CRISPR di­ag­nos­tic out­fit, grabs $80M to go be­yond Covid-19

Last year
Financing

Pre­ci­sion im­munol­o­gy play­er bags $110M to fund its work on 'dis­ease sig­na­ture' tests

Last year
Financing
12 Next page Last page
A service from the Financial Times